Literature DB >> 1511598

Ranking radiotherapy treatment plans using decision-analytic and heuristic techniques.

N L Jain1, M G Kahn.   

Abstract

Radiotherapy treatment optimization is done by generating a set of tentative treatment plans, evaluating them, and selecting the plan closest to achieving a set of conflicting treatment objectives. The evaluation of potential plans involves making trade-offs among competing possible outcomes. Multiattribute decision theory provides a framework for specifying such trade-offs and using them to select optimal actions. Using these concepts, we have developed a plan-ranking model which ranks a set of tentative treatment plans from best to worst. Heuristics are used to refine this model so that it reflects the clinical condition of the patient being treated and the practice preference of the physician prescribing the treatment. A figure of merit is computed for each tentative plan and is used to rank the plans. The approach described is very general and can be used for other medical domains having similar characteristics. The figure of merit can also be used as an objective function by computer programs that attempt to automatically generate an optimal treatment plan.

Entities:  

Mesh:

Year:  1992        PMID: 1511598     DOI: 10.1016/0010-4809(92)90027-8

Source DB:  PubMed          Journal:  Comput Biomed Res        ISSN: 0010-4809


  2 in total

1.  Objective evaluation of radiation treatment plans.

Authors:  N L Jain; M G Kahn
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1993

2.  Inverse treatment planning for spinal robotic radiosurgery: an international multi-institutional benchmark trial.

Authors:  Oliver Blanck; Lei Wang; Wolfgang Baus; Jimm Grimm; Thomas Lacornerie; Joakim Nilsson; Sergii Luchkovskyi; Isabel Palazon Cano; Zhenyu Shou; Myriam Ayadi; Harald Treuer; Romain Viard; Frank-Andre Siebert; Mark K H Chan; Guido Hildebrandt; Jürgen Dunst; Detlef Imhoff; Stefan Wurster; Robert Wolff; Pantaleo Romanelli; Eric Lartigau; Robert Semrau; Scott G Soltys; Achim Schweikard
Journal:  J Appl Clin Med Phys       Date:  2016-05-08       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.